Last reviewed · How we verify

NCT06964425

Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study

Recruiting now NA Last updated 2 July 2025
What this trial tests

NA trial testing Endoscopic retrograde cholangiopancreatography (ERCP) in Cholangiocarcinoma, Extrahepatic in 20 participants. Currently enrolling.

Timeline
4 February 2023
Primary endpoint
31 May 2025
30 July 2025

Quick facts

Lead sponsorUniversity Hospital Olomouc
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment20
Start date4 February 2023
Primary completion31 May 2025
Estimated completion30 July 2025
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Olomouc

Who can join

18 and older, any sex, with Cholangiocarcinoma, Extrahepatic or Cholangiocarcinoma of the Extrahepatic Bile Duct. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diagnosis of extrahepatic cholangiocarcinoma is challenging because the yield of imaging and tissue sampling is limited. Raman spectroscopy is an optical method based on the analysis of scattered monochromatic light. Raman spectroscopy is able to provide a molecular 'fingerprint' of the tissue to determine its type. The aim of this pilot study was to develop a methodology for in vivo Raman spectroscopy in bile ducts to improve the current diagnostic capabilities of extrahepatic cholangiocarcinoma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Endoscopic retrograde cholangiopancreatography (ERCP)

Trials testing the same drug.

Other University Hospital Olomouc trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06964425.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing